Author:
Powell Matthew A.,Olawaiye Alexander B.,Bermudez Adriana,Bhosale Priya R.,Grigsby Perry W.,Copeland Larry J.,Dizon Don S.,Erickson Beth A.,Hagemann Ian S.,Portelance Lorraine,Prat Jaime,Mutch David G.
Publisher
Springer International Publishing
Reference20 articles.
1. Lalwani N, Dubinsky T, Javitt MC, et al. ACR Appropriateness Criteria(R) pretreatment evaluation and follow-up of endometrial cancer. Ultrasound Q. Mar 2014;30(1):21–28.
2. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. Jan 10 2009;373(9658):125–136.
3. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecologic oncology. Jul 2002;86(1):38–44.
4. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. May 2009;105(2):103–104.
5. Kattan MW, Hess KR, Amin MB, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA: a cancer journal for clinicians. Jan 19 2016.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献